कोशिश गोल्ड - मुक्त
MENTAL HEALTH DEVICES: SCIENCE OR SNAKE OIL?
Mint Mumbai
|October 20, 2025
Startups are taking mental health care beyond pills and therapy, through wearable devices
It's a quiet Tuesday evening inside the Blue Tokai Coffee Roasters cafe in Koramangala, Bengaluru. The aroma of freshly brewed coffee hangs in the air as I'm handed a device that looks fairly simple, black in colour and something between a headband and a headset, except it doesn’t cover the ears. There are no flashy screens, no blinking lights, no music to play. It isn’t built to count your steps or track your sleep. Instead, it goes a step ahead and is aimed at speaking to your brain.
“This might feel like a slight tingling,” says Jai Sharma, co-founder of Mave Health, a Bengaluru-based mental wellness startup, as he connects the headset to an app on his phone. He taps a button on his phone. A few seconds later, I feel it, a faint, rhythmic pulse against my forehead, subtle enough to ignore but impossible not to notice. It’s called neurostimulation, and it promises to do what few wearables have dared to attempt: calm the mind, ease stress, sharpen focus and, in some cases, assist in treating conditions such as depression, anxiety, Attention Deficit Hyperactivity Disorder (ADHD), Obsessive-Compulsive Disorder (OCD) or addiction.
For years, India’s wellness tech has revolved around metrics and tracking: how fast you ran, how well you slept, how many calories you burned. But startups such as Mave Health, Marbles Health, InnerGize, UK-based Mindspire and Israel-based BrainQ are rewriting that script. They are building devices that don’t just measure mental wellbeing, but aim to improve it.
Their approach combines neuroscience, design and accessibility with the ambition to bring brain-tech out of laboratories and into everyday life. These startups are running pilots, seeking regulatory clearances and raising early rounds of capital to make neurostimulation both affordable and mainstream.
यह कहानी Mint Mumbai के October 20, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Mumbai
English's place in history is not black and white
In 1784, two white men joined forces to establish an English school in Thanjavur, Tamil Nadu.
4 mins
December 13, 2025
Mint Mumbai
Rising costs force Indian firms to rewrite employee benefits
Indian companies are rethinking the benefits they offer their staff, such as healthcare, retiral plans, well-being perks, and leave, as they seek to control budgets while retaining top talent without compromising on employee experience.
3 mins
December 13, 2025
Mint Mumbai
A modern-day throwback to 'Malgudi Days'
Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru
3 mins
December 13, 2025
Mint Mumbai
Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay
The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh
3 mins
December 13, 2025
Mint Mumbai
IiAS puts Bhatia, IndiGo board under the scanner
Institutional Investor Advisory Services India Ltd (IiAS) has faulted IndiGo promoter and managing director (MD) Rahul Bhatia for not leading from the front when the airline is facing its most challenging operational episode, even as it has sought a review of the current board structure which allows him to nominate half of the board.
2 mins
December 13, 2025
Mint Mumbai
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
3 mins
December 13, 2025
Mint Mumbai
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
3 mins
December 13, 2025
Mint Mumbai
CBDC safer option, stablecoins pose greater risk: RBI
Central bank digital currencies are a far safer option than stablecoins, which pose greater risks than their purported benefits, according to Reserve Bank of India (RBI) deputy governor T. Rabi Sankar.
2 mins
December 13, 2025
Mint Mumbai
Sebi weighs easier unified penalty rules for listed cos
Explores framework like the one for brokers that standardized and reduced fines
3 mins
December 13, 2025
Listen
Translate
Change font size
